MENLO THERAPEUTICS
(586858102)
Fondsberichterstattung Bestände von MENLO THERAPEUTICS gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| Great Point Partners LLC | 1,733,882 | $10,386,000k | Jun 30, 2019 | Aug 14, 2019 | |
| VIVO Capital LLC | 4,011,236 | $24,027k | Jun 30, 2019 | Aug 13, 2019 | |
| First Manhattan Co | 2,226,192 | $13,334k | Jun 30, 2019 | Aug 16, 2019 | |
| Mangrove Partners | 853,326 | $5,111k | Jun 30, 2019 | Aug 14, 2019 | |
| Baker BROS Advisors LP | 700,000 | $4,193k | Jun 30, 2019 | Aug 14, 2019 | |
| Orbimed Advisors LLC | 673,700 | $4,035k | Jun 30, 2019 | Aug 14, 2019 | |
| Dafna Capital Management LLC | 600,030 | $3,594k | Jun 30, 2019 | Aug 14, 2019 | |
| Deerfield Management Company LP Series C | 198,451 | $1,189k | Jun 30, 2019 | Aug 14, 2019 | |
| Acadian Asset Management LLC | 37,914 | $227k | Jun 30, 2019 | Aug 8, 2019 |